Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma

Veracyte (Nasdaq: VCYT) today announced a multi-year partnership with Acerta Pharma, the hematology research and development arm of AstraZeneca (LSE/STO/NYSE: AZN), to provide genomic information that...

VCYT : 30.15 (-0.07%)
Veracyte Inc Falls 1.20% on Heavy Volume: Watch For Potential Rebound

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $27.90 to a high of $28.58. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $28.11...

VCYT : 30.15 (-0.07%)
Veracyte Acquires Exclusive License to NanoString Diagnostics Platform, Positioning Veracyte To Expand Its Genomic Testing Business Globally

--Provides pathway for long-term revenue growth and margin expansion

VCYT : 30.15 (-0.07%)
SmarTrend Watching for Potential Rebound in Shares of Veracyte Inc After 4.13% Loss

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $27.38 to a high of $28.75. Yesterday, the shares fell 4.1%, which took the trading range below the 3-day low of $28.16...

VCYT : 30.15 (-0.07%)
Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer

Veracyte, Inc. (Nasdaq: VCYT) today announced new data that advance understanding of the frequency, positive predictive value and co-occurrence of genomic alterations that are targeted by newly available...

VCYT : 30.15 (-0.07%)
Veracyte Announces New Data Characterizing Genomic Alterations in Thyroid Cancer To Be Presented at 89th Annual Meeting of the American Thyroid Association

Veracyte, Inc. (Nasdaq: VCYT) announced today that new data advancing the understanding of genomic alterations - specifically, NTRK, RET, BRAF and ALK fusions - that are targeted by new precision medicine...

VCYT : 30.15 (-0.07%)
Veracyte Inc Down 7.8% Since SmarTrend Downtrend Call (VCYT)

SmarTrend identified a Downtrend for Veracyte Inc (NASDAQ:VCYT) on August 5th, 2019 at $24.26. In approximately 3 months, Veracyte Inc has returned 7.79% as of today's recent price of $22.37.

VCYT : 30.15 (-0.07%)
Watch for Veracyte Inc to Potentially Rebound After Falling 15.13% Yesterday

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $20.09 to a high of $21.44. Yesterday, the shares fell 15.1%, which took the trading range below the 3-day low of $20.79...

VCYT : 30.15 (-0.07%)
Veracyte: 3Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $730,000 in its third quarter.

VCYT : 30.15 (-0.07%)
Veracyte Announces Third Quarter 2019 Financial Results and Business Progress

--Genomic Test Volume Grew 24% to 9,941

VCYT : 30.15 (-0.07%)
Veracyte Announces New Clinical Data Showing First-Ever Noninvasive Nasal Swab Test Can Enable Early Lung Cancer Detection and Diagnosis

--Conference call and webcast today at 5:00 p.m. ET to review third quarter 2019 Financial results and the new nasal swab test data

VCYT : 30.15 (-0.07%)
Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive

Veracyte, Inc. (Nasdaq: VCYT) today announced data demonstrating the clinical validity of its next-generation Percepta(R) Genomic Sequencing Classifier (GSC) and the clinical utility of its first-generation...

VCYT : 30.15 (-0.07%)
Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis

Veracyte, Inc. (Nasdaq: VCYT) announced that data from three studies presented at the annual meeting of the American College of Chest Physicians(R) (CHEST 2019) demonstrate that the Envisia(R) Genomic...

VCYT : 30.15 (-0.07%)
Look for Shares of Veracyte Inc to Potentially Rebound after Yesterday's 1.92% Sell Off

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $24.48 to a high of $25.69. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $24.59...

VCYT : 30.15 (-0.07%)
Shares of Pfenex Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PFNX, VCYT , KPTI , GBT , REGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 17.04 (-9.51%)
VCYT : 30.15 (-0.07%)
PFNX : 12.30 (-1.76%)
Veracyte Inc Rises 4.08% on Heavy Volume: Watch For Potential Pullback

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.30 to a high of $24.30. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $23.89...

VCYT : 30.15 (-0.07%)
Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the third quarter 2019 and business progress after the close of market on Tuesday, October 22, 2019. Company...

VCYT : 30.15 (-0.07%)
Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that preliminary clinical data for the company's noninvasive nasal swab test - the first of its kind - for early detection of lung cancer will be presented...

VCYT : 30.15 (-0.07%)
After Yesterday's Decline of 1.02%, Veracyte Inc Offers Investors Better Value

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.68 to a high of $24.56. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $24.43...

VCYT : 30.15 (-0.07%)
Personalis Appoints Karin Eastham to Its Board of Directors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has appointed Karin Eastham as an independent director to its Board of Directors. Ms. Eastham brings more...

ILMN : 324.72 (-0.38%)
MOR : 32.88 (-2.03%)
VCYT : 30.15 (-0.07%)
PSNL : 11.76 (-5.24%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -0.35 , SEDG +2.05 , THC unch , TER -0.21 , LITE -0.79
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar